Gene: GNAS

2778
AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PITA3|POH|SCG6|SgVI
GNAS complex locus
protein-coding
20q13.32
Ensembl:ENSG00000087460 MIM:139320 Vega:OTTHUMG00000033069 UniprotKB:O95467
NG_016194.1
PubMed
ND|AD
4   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.752e-1 (AD)  8.022e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg01538522chr20:57463974GNASPromoter1.686e-5Alcohol use disorders26763658
cg05926269chr20:57463906GNASPromoter9.150e-5Alcohol use disorders26763658
cg03837903chr20:57464000GNASPromoter2.279e-4Alcohol use disorders26763658
cg01817393chr20:57427642GNASPromoter2.578e-4Alcohol use disorders26763658
cg23159236chr20:57464002GNASPromoter3.106e-4Alcohol use disorders26763658
cg20126878chr20:57464571GNASGene body3.227e-4Alcohol use disorders26763658
cg26767990chr20:57463615GNASPromoter4.630e-4Alcohol use disorders26763658
cg25983380chr20:57465439GNASPromoter6.157e-4Alcohol use disorders26763658
cg00267746chr20:57463984GNASPromoter6.500e-4Alcohol use disorders26763658
cg05558390chr20:57415377GNASPromoter7.237e-4Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
NGRN0.952
ATP6V1F0.951
OAZ10.948
RAD23A0.945
GAPDH0.944
MORF4L10.942
PEBP10.941
CALM20.941
CHMP4B0.94
MRPS210.94

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.873
OR4F29-0.851
GJA3-0.215
KCNJ15-0.21
KLRB1-0.208
UPK1B-0.208
TFPI2-0.206
ABCA13-0.206
EVA1A-0.204
PTPN7-0.199

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB02587ColforsinSmall Molecule66575-29-9Experimental|InvestigationalTarget
DB068432',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATESmall MoleculeExperimentalTarget
ID Drug Name Action PubMed
C0602291-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
C0602291-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
C0297902,2',3',4,4',5-hexachlorobiphenyl"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GNAS mRNA"23829299
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA"19167446
C0163923,3'-diindolylmethane"3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA]"11179685
C5495433-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid analog results in decreased expression of GNAS mRNA25716159
C1102584,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) inhibits the reaction [[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
C1102584,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) inhibits the reaction [[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
C1102584,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) results in decreased activity of GNAS protein"23022524
C1102584,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) results in decreased activity of GNAS protein"19654912
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal results in decreased expression of GNAS mRNA12419474
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C5455016alpha-ethyl-23(S)-methylcholic acid"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
C5455016alpha-ethyl-23(S)-methylcholic acid"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) inhibits the reaction [[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
C5455016alpha-ethyl-23(S)-methylcholic acid[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein23022524
C5455016alpha-ethyl-23(S)-methylcholic acid[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium23022524
C5455016alpha-ethyl-23(S)-methylcholic acid[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Cyclic AMP23022524
C5455016alpha-ethyl-23(S)-methylcholic acid[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols23022524
D000242Cyclic AMPGNAS protein promotes the reaction [[cicaprost results in increased activity of PTGIR protein] which results in increased abundance of Cyclic AMP]11895442
D000242Cyclic AMP[[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OLFR49 protein] which results in increased abundance of Cyclic AMP15598656
D000242Cyclic AMP[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Cyclic AMP23022524
D000242Cyclic AMP[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Cyclic AMP23022524
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of GNAS gene27153756
D000526Alprenolol[Alprenolol co-treated with ADRB2 protein] results in increased expression of GNAS protein10455254
C032311aluminum fluoridealuminum fluoride results in increased activity of GNAS protein7961906
D000638AmiodaroneAmiodarone results in increased expression of GNAS mRNA19774075
D000643Ammonium ChlorideAmmonium Chloride affects the expression of GNAS mRNA16483693
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of GNAS mRNA24449571
C015001arsenitearsenite affects the methylation of GNAS promoter23974009
D001280AtrazineAtrazine results in decreased expression of GNAS mRNA25929836
C028559bathocuproine sulfonate[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of GNAS mRNA15477007
D004958Estradiol"3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA]"11179685
D004958EstradiolEstradiol results in decreased expression of GNAS mRNA11179685
D004958EstradiolTetrachlorodibenzodioxin inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA]11179685
D017298BisoprololBisoprolol results in increased expression of GNAS mRNA20668454
C006780bisphenol Abisphenol A results in decreased methylation of GNAS promoter27271280
C006780bisphenol Abisphenol A results in increased expression of GNAS mRNA29275510
C006780bisphenol Abisphenol A affects the expression of GNAS mRNA21636974
C006780bisphenol Abisphenol A results in decreased methylation of GNAS promoter27312807
C006780bisphenol Abisphenol A results in increased expression of GNAS mRNA26063408
C006780bisphenol Abisphenol A results in increased methylation of GNAS promoter27312807
C006780bisphenol Abisphenol A results in increased expression of GNAS mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of GNAS gene28505145
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of GNAS mRNA12419474
C018475butyraldehydebutyraldehyde results in decreased expression of GNAS mRNA26079696
D002110CaffeineCaffeine results in decreased expression of GNAS protein15708489
D002118Calcium[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium23022524
D002118Calcium[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium23022524
D002220CarbamazepineCarbamazepine affects the expression of GNAS mRNA24752500
C043211carvedilol[carvedilol co-treated with ADRB2 protein] results in increased expression of GNAS protein10455254
C043211carvedilolcarvedilol results in increased expression of GNAS mRNA20668454
D000068579CelecoxibCelecoxib results in increased expression of GNAS mRNA28201806
D002713Chlorine[Ozone co-treated with Chlorine] results in decreased expression of GNAS mRNA18636392
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of GNAS mRNA23650126
C100187chloropicrinchloropicrin results in decreased expression of GNAS mRNA26352163
D002737ChloropreneChloroprene results in increased expression of GNAS mRNA23125180
D002772Cholera ToxinCholera Toxin promotes the reaction [GNAS protein modified form binds to Guanosine Triphosphate]17136323
D002772Cholera ToxinCholera Toxin results in increased activity of and results in increased ADP-ribosylation of GNAS protein17136323
D002784CholesterolCholesterol inhibits the reaction [Progesterone results in increased expression of GNAS protein]19221014
C043867cicaprostcicaprost promotes the reaction [PTGIR protein binds to GNAS protein]11895442
C043867cicaprostGNAS protein promotes the reaction [[cicaprost results in increased activity of PTGIR protein] which results in increased abundance of Cyclic AMP]11895442
C108217citronellalEgtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to citronellal]15598656
C108217citronellalEgtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OLFR49 protein]15598656
C108217citronellalGNAS protein results in increased susceptibility to citronellal15598656
C108217citronellal[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OLFR49 protein15598656
C108217citronellal[[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OLFR49 protein] which results in increased abundance of Cyclic AMP15598656
D003024ClozapineClozapine results in decreased expression of GNAS mRNA15860345
C018021cobaltous chloridecobaltous chloride results in decreased expression of GNAS mRNA19320972
D019327Copper SulfateCopper Sulfate results in decreased activity of GNAS protein15546818
D019327Copper SulfateCopper Sulfate results in decreased activity of GNAS protein15546818
D019327Copper SulfateCopper Sulfate inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) binds to GNAS protein]15546818
D019327Copper SulfateCopper Sulfate inhibits the reaction [Guanosine Diphosphate binds to GNAS protein]15546818
D019327Copper SulfateCopper Sulfate inhibits the reaction [Guanosine Triphosphate binds to GNAS protein]15546818
D016572CyclosporineCyclosporine results in decreased methylation of GNAS promoter27989131
D003907DexamethasoneDexamethasone results in increased expression of GNAS mRNA7730645
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of GNAS mRNA21266533
D002945CisplatinCisplatin inhibits the reaction [GNAS protein results in increased expression of XIAP mRNA]21255191
D002945CisplatinGNAS protein inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]21255191
D002945Cisplatin[GNAS protein results in increased expression of XIAP protein] which results in decreased susceptibility to Cisplatin21255191
D002945CisplatinGNAS results in decreased susceptibility to Cisplatin21849418
D004008DiclofenacDiclofenac affects the expression of GNAS mRNA24752500
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate affects the expression of GNAS mRNA21636974
D004280DobutamineGNAS gene SNP results in increased susceptibility to Dobutamine19542315
D004317DoxorubicinDoxorubicin affects the expression of GNAS protein29385562
D004317Doxorubicin[GNAS protein results in increased expression of XIAP protein] which results in decreased susceptibility to Doxorubicin21255191
D004317DoxorubicinDoxorubicin results in decreased expression of GNAS mRNA15353854
D004533Egtazic AcidEgtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to citronellal]15598656
D004533Egtazic AcidEgtazic Acid inhibits the reaction [[GNAS protein results in increased susceptibility to citronellal] which results in increased activity of OLFR49 protein]15598656
D004533Egtazic AcidEgtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to Isoproterenol]15598656
C118739entinostatentinostat results in increased expression of GNAS mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
D004785Environmental PollutantsEnvironmental Pollutants results in decreased expression of GNAS mRNA12655031
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in decreased expression of GNAS mRNA23649840
D005038EthylnitrosoureaEthylnitrosourea results in increased mutagenesis of GNAS gene16724327
D018120FinasterideFinasteride results in increased expression of GNAS mRNA24136188
D005419FlavonoidsFlavonoids results in decreased expression of GNAS mRNA18035473
D005473FluoxetineFluoxetine results in decreased expression of GNAS mRNA1426031
D005473FluoxetineFluoxetine results in increased expression of GNAS mRNA21852994
D005492Folic Acid[Folic Acid co-treated with sodium arsenite] results in increased methylation of GNAS mRNA22959928
C056933fumonisin B1fumonisin B1 results in increased expression of GNAS mRNA16221962
D019833Genistein[Genistein co-treated with Methoxychlor] results in increased expression of GNAS mRNA21782745
C002963geranylgeranyl pyrophosphategeranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of GNAS protein]22144680
D006153Guanosine DiphosphateCopper Sulfate inhibits the reaction [Guanosine Diphosphate binds to GNAS protein]15546818
D006153Guanosine Diphosphatetetrafluoroaluminate promotes the reaction [Guanosine Diphosphate binds to GNAS protein]15546818
D006153Guanosine DiphosphateZinc Sulfate inhibits the reaction [Guanosine Diphosphate binds to GNAS protein]15546818
D016244Guanosine 5'-O-(3-Thiotriphosphate)Copper Sulfate inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) binds to GNAS protein]15546818
D016244Guanosine 5'-O-(3-Thiotriphosphate)Zinc Sulfate inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) binds to GNAS protein]15546818
D006160Guanosine TriphosphateCholera Toxin promotes the reaction [GNAS protein modified form binds to Guanosine Triphosphate]17136323
D006160Guanosine TriphosphateCopper Sulfate inhibits the reaction [Guanosine Triphosphate binds to GNAS protein]15546818
D006160Guanosine TriphosphateZinc Sulfate inhibits the reaction [Guanosine Triphosphate binds to GNAS protein]15546818
D006220HaloperidolHaloperidol results in decreased expression of GNAS mRNA15860345
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of GNAS mRNA12419474
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased secretion of GNAS mRNA21179422
C026777ICI 118551[ICI 118551 co-treated with ADRB2 protein] results in increased expression of GNAS protein10455254
C026777ICI 118551ICI 118551 results in increased expression of GNAS protein10455254
D007213IndomethacinIndomethacin results in decreased expression of GNAS protein15579502
D007545IsoproterenolEgtazic Acid inhibits the reaction [GNAS protein results in increased susceptibility to Isoproterenol]15598656
D007545IsoproterenolGNAS protein results in increased susceptibility to Isoproterenol15598656
D007545IsoproterenolGNAS protein affects the susceptibility to [Potassium Chloride co-treated with Isoproterenol]10696522
D007545IsoproterenolIsoproterenol affects the expression of and affects the localization of GNAS protein12376418
C561695(+)-JQ1 compoundGNAS protein results in decreased susceptibility to (+)-JQ1 compound23430699
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of GNAS mRNA23086925
D007854LeadLead affects the expression of GNAS mRNA28903495
D007854LeadLead affects the splicing of GNAS mRNA28903495
D007854LeadLead results in increased expression of GNAS mRNA19921347
C042720mercuric bromidemercuric bromide results in increased expression of GNAS mRNA26272509
D008731Methoxychlor[Genistein co-treated with Methoxychlor] results in increased expression of GNAS mRNA21782745
D008731MethoxychlorMethoxychlor results in decreased expression of GNAS mRNA23303685
D008731MethoxychlorMethoxychlor results in increased expression of GNAS mRNA21782745
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of GNAS protein25809596
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of GNAS mRNA28001369
D008798Mevalonic AcidMevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of GNAS protein]22144680
D009020MorphineMorphine results in increased expression of GNAS mRNA17893922
D009020MorphineMorphine results in increased expression of GNAS protein17893922
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of GNAS mRNA"25620056
C051752nefazodonenefazodone results in decreased expression of GNAS mRNA24136188
C012655nimesulidenimesulide results in decreased expression of GNAS mRNA24136188
D009638NorepinephrineNorepinephrine promotes the reaction [ADRB1 protein results in increased activity of GNAS protein]17200720
D009828Oleanolic Acid"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
D009828Oleanolic Acid"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) inhibits the reaction [[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
D009828Oleanolic Acid[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein23022524
D009828Oleanolic Acid[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Calcium23022524
D009828Oleanolic Acid[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased abundance of Cyclic AMP23022524
D009828Oleanolic Acid[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols23022524
D010100OxygenOxygen deficiency results in increased expression of GNAS mRNA20862257
D010100OxygenOxygen deficiency results in decreased expression of GNAS protein10192281
D010126OzoneOzone results in decreased expression of GNAS mRNA24336422
D010126Ozone[Ozone co-treated with Chlorine] results in decreased expression of GNAS mRNA18636392
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of GNAS mRNA26272509
D010269ParaquatParaquat results in increased expression of GNAS mRNA16797015
D010269ParaquatParaquat affects the expression of GNAS mRNA15206577
D010424PentobarbitalPentobarbital affects the expression of GNAS mRNA12199159
D010622PhencyclidinePhencyclidine results in increased expression of GNAS mRNA12105081
D010634PhenobarbitalPhenobarbital results in increased expression of GNAS mRNA12082028
D010656PhenylephrineGNAS protein affects the susceptibility to Phenylephrine10696522
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate affects the expression of GNAS mRNA26272509
D010716Phosphatidylinositols"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
D010716Phosphatidylinositols"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
D010716Phosphatidylinositols"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) inhibits the reaction [[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
D010716Phosphatidylinositols"4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate) inhibits the reaction [[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols]"23022524
D010716Phosphatidylinositols[[6alpha-ethyl-23(S)-methylcholic acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols23022524
D010716Phosphatidylinositols[[Oleanolic Acid binds to and results in increased activity of GPBAR1 protein] which results in increased activity of GNAS protein] which results in increased hydrolysis of Phosphatidylinositols23022524
C006253pirinixic acidpirinixic acid results in increased expression of GNAS mRNA16221962|1830175
C006253pirinixic acidpirinixic acid results in increased expression of GNAS mRNA16940010
D011189Potassium ChlorideGNAS protein affects the susceptibility to [Potassium Chloride co-treated with Isoproterenol]10696522
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of GNAS mRNA22698814
D011374ProgesteroneCAV3 mutant form inhibits the reaction [Progesterone results in increased expression of GNAS protein]19221014
D011374ProgesteroneProgesterone results in increased expression of GNAS protein19221014
D011374ProgesteroneCAV3 mutant form inhibits the reaction [Progesterone results in increased expression of GNAS protein]19221014
D011374ProgesteroneCholesterol inhibits the reaction [Progesterone results in increased expression of GNAS protein]19221014
D011374ProgesteroneProgesterone results in increased expression of GNAS protein19221014
D011374ProgesteroneProgesterone results in increased expression of GNAS protein15469997
D011433Propranolol[Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein10455254
D011433PropranololPropranolol results in increased expression of GNAS mRNA20668454
D011441PropylthiouracilPropylthiouracil results in increased expression of GNAS mRNA24780913
C020972pyrrolidine dithiocarbamic acid[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of GNAS mRNA15477007
D012110ReserpineReserpine results in decreased expression of GNAS protein alternative form1336118
D012110ReserpineReserpine results in increased expression of GNAS mRNA8419537
D012110ReserpineReserpine results in increased expression of GNAS protein11264240
C059514resveratrolresveratrol results in decreased expression of GNAS mRNA22610192
D012524SarinSarin results in decreased expression of GNAS mRNA19522546
D012643Selenium[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA19244175
D012643SeleniumSelenium results in decreased expression of GNAS mRNA19244175
D012822Silicon DioxideSilicon Dioxide results in increased expression of GNAS mRNA18685790
D019821Simvastatingeranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of GNAS protein]22144680
D019821SimvastatinMevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of GNAS protein]22144680
D019821SimvastatinSimvastatin results in decreased expression of GNAS protein22144680
D019821SimvastatinSimvastatin results in increased expression of GNAS mRNA22144680
C017947sodium arsenite[Folic Acid co-treated with sodium arsenite] results in increased methylation of GNAS mRNA22959928
D012999SomanSoman results in increased expression of GNAS mRNA19281266
D013467SulindacSulindac results in increased expression of GNAS mRNA24136188
D013726TerbutalineTerbutaline affects the localization of GNAS protein12376418
D013726TerbutalineTerbutaline results in increased localization of GNAS protein alternative form12376418
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA]11179685
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of GNAS mRNA21570461|2637764
C050992tetrafluoroaluminatetetrafluoroaluminate promotes the reaction [Guanosine Diphosphate binds to GNAS protein]15546818
D013806TheophyllineTheophylline results in decreased expression of GNAS protein15708489
C009495titanium dioxidetitanium dioxide results in decreased expression of GNAS mRNA23557971
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased expression of GNAS mRNA28065790
D014212TretinoinTretinoin results in decreased expression of GNAS mRNA21934132
D014241TrichloroethylenePPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of GNAS mRNA]15363585
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of GNAS mRNA24935251|2627250
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of GNAS mRNA"26179874
D014415TunicamycinTunicamycin results in decreased expression of GNAS mRNA17127020
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNAS mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of GNAS mRNA23179753
D014635Valproic AcidValproic Acid results in increased expression of GNAS mRNA24383497|2493525
D014635Valproic AcidValproic Acid affects the expression of GNAS mRNA17292431
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of GNAS gene25560391
D014810Vitamin E[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA19244175
C111237vorinostatvorinostat results in decreased expression of GNAS mRNA27188386
D019287Zinc SulfateZinc Sulfate results in decreased activity of GNAS protein15546818
D019287Zinc SulfateZinc Sulfate results in decreased activity of GNAS protein15546818
D019287Zinc SulfateZinc Sulfate inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) binds to GNAS protein]15546818
D019287Zinc SulfateZinc Sulfate inhibits the reaction [Guanosine Diphosphate binds to GNAS protein]15546818
D019287Zinc SulfateZinc Sulfate inhibits the reaction [Guanosine Triphosphate binds to GNAS protein]15546818

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0001664G-protein coupled receptor binding-IBA21873635  
GO:0003924GTPase activity-IBA21873635  
GO:0005159insulin-like growth factor receptor binding-IBA21873635  
GO:0005515protein binding-IPI12719376  23353685  
GO:0005525GTP binding-IEA-  
GO:0031683G-protein beta/gamma-subunit complex binding-IBA21873635  
GO:0031698beta-2 adrenergic receptor binding-IBA21873635  
GO:0031748D1 dopamine receptor binding-IBA21873635  
GO:0031852mu-type opioid receptor binding-IBA21873635  
GO:0035255ionotropic glutamate receptor binding-IBA21873635  
GO:0046872metal ion binding-IEA-  
GO:0051430corticotropin-releasing hormone receptor 1 binding-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0001894tissue homeostasis-IEA-  
GO:0001958endochondral ossification-IEA-  
GO:0006112energy reserve metabolic process-IEA-  
GO:0006306DNA methylation-IEA-  
GO:0007188adenylate cyclase-modulating G-protein coupled receptor signaling pathway-IBA21873635  
GO:0007189adenylate cyclase-activating G-protein coupled receptor signaling pathway-IMP12719376  
GO:0007191adenylate cyclase-activating dopamine receptor signaling pathway-IBA21873635  
GO:0007606sensory perception of chemical stimulus-IBA21873635  
GO:0035116embryonic hindlimb morphogenesis-IEA-  
GO:0035264multicellular organism growth-IEA-  
GO:0040032post-embryonic body morphogenesis-IEA-  
GO:0042493response to drug-IEA-  
GO:0043588skin development-IEA-  
GO:0045669positive regulation of osteoblast differentiation-IEA-  
GO:0045672positive regulation of osteoclast differentiation-IEA-  
GO:0048589developmental growth-IMP12719376  
GO:0048701embryonic cranial skeleton morphogenesis-IEA-  
GO:0051216cartilage development-IEA-  
GO:0060348bone development-IMP12719376  
GO:0070527platelet aggregation-IMP12719376  
GO:0071514genetic imprinting-IEA-  
GO:2000828regulation of parathyroid hormone secretion-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005829cytosol-IDA12719376  
GO:0005829cytosol-ISS-  
GO:0005834heterotrimeric G-protein complex-IBA21873635  
GO:0016020membrane-HDA19946888  
GO:0016020membrane-IDA12719376  
GO:0016020membrane-ISS-  
GO:0016324apical plasma membrane-IEA-  
GO:0030425dendrite-IEA-  
GO:0070062extracellular exosome-HDA19199708  20458337  23533145  
KEGG ID KEGG Term
hsa04020Calcium signaling pathway
hsa04270Vascular smooth muscle contraction
hsa04540Gap junction
hsa04730Long-term depression
hsa04742Taste transduction
hsa04912GnRH signaling pathway
hsa04916Melanogenesis
hsa04962Vasopressin-regulated water reabsorption
hsa04970Salivary secretion
hsa04971Gastric acid secretion
hsa04972Pancreatic secretion
hsa04976Bile secretion
hsa05110Vibrio cholerae infection
hsa05142Chagas disease (American trypanosomiasis)
hsa05146Amoebiasis
hsa05414Dilated cardiomyopathy
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisIEA
R-HSA-109582HemostasisTAS
R-HSA-1430728MetabolismTAS
R-HSA-1430728MetabolismIEA
R-HSA-162582Signal TransductionTAS
R-HSA-162582Signal TransductionIEA
R-HSA-163359Glucagon signaling in metabolic regulationTAS
R-HSA-163685Integration of energy metabolismTAS
R-HSA-163685Integration of energy metabolismIEA
R-HSA-164378PKA activation in glucagon signallingTAS
R-HSA-372790Signaling by GPCRTAS
R-HSA-372790Signaling by GPCRIEA
R-HSA-373080Class B/2 (Secretin family receptors)TAS
R-HSA-381676Glucagon-like Peptide-1 (GLP1) regulates insulin secretionTAS
R-HSA-381676Glucagon-like Peptide-1 (GLP1) regulates insulin secretionIEA
R-HSA-382551Transport of small moleculesTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-388396GPCR downstream signallingIEA
R-HSA-392851Prostacyclin signalling through prostacyclin receptorIEA
R-HSA-392851Prostacyclin signalling through prostacyclin receptorTAS
R-HSA-418346Platelet homeostasisIEA
R-HSA-418346Platelet homeostasisTAS
R-HSA-418555G alpha (s) signalling eventsTAS
R-HSA-418555G alpha (s) signalling eventsIEA
R-HSA-418594G alpha (i) signalling eventsIEA
R-HSA-418597G alpha (z) signalling eventsIEA
R-HSA-420092Glucagon-type ligand receptorsTAS
R-HSA-422356Regulation of insulin secretionTAS
R-HSA-422356Regulation of insulin secretionIEA
R-HSA-432040Vasopressin regulates renal water homeostasis via AquaporinsTAS
R-HSA-445717Aquaporin-mediated transportTAS
R-HSA-500792GPCR ligand bindingTAS
R-HSA-5358351Signaling by HedgehogTAS
R-HSA-5610787Hedgehog 'off' stateTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28776576GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas. (2017 Dec)Ritterhouse LLMod Pathol
24884436Chronic alcohol consumption from adolescence-to-adulthood in mice--hypothalamic gene expression changes in the dilated cardiomyopathy signaling pathway. (2014 May 9)Zou HBMC Neurosci
24828667Small-cell lung cancers in patients who never smoked cigarettes. (2014 Jun)Varghese AMJ Thorac Oncol
23116464Beckwith Wiedemann imprinting defect found in leucocyte but not buccal DNA in a child born small for gestational age. (2012 Nov 1)Murphy RBMC Med Genet